New Paradigm Needs Clear Switch Criteria, Standard Dispensing Rules
This article was originally published in The Tan Sheet
Executive Summary
Health care industry stakeholders urge FDA to standardize criteria for determining a drug’s switch potential under a new paradigm for nonprescription approvals as well as processes for ordering and dispensing the drugs once they are switched.